Aemetis, Inc. AMTX
Major Chemicals · data as of November 13, 2026
Aemetis, Inc. (AMTX) is a industrial company listed in the US with a market value of about $88M. In the twelve months to September 30, 2026 it had revenue of $249M and net income of -$31M, a net margin of -12.5%.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is future growth (2/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 4% a year, a 5-year average ROIC of -41%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 65% below the current price.
About Aemetis
Aemetis is listed in the US and classified in major chemicals. Revenue went from $208M in 2014 to $198M in 2025, a decline of about 0.5% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 73% over three years (dilution for shareholders).
Score: 0.8 / 5
Checks passed
- 3-year revenue growth above 10% a year
- Profit margin improving
- ROE above 15%
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $249M | $198M | $268M | $77M | $28M | $212M | $166M | $202M | $172M | $150M | $143M |
| Net income | -$31M | -$77M | -$88M | -$46M | -$108M | -$47M | -$37M | -$39M | -$36M | -$32M | -$16M |
| Free cash flow | -$37M | -$23M | -$53M | -$19M | -$62M | -$47M | -$17M | -$11M | -$10M | -$10M | -$258000 |
| EPS (diluted) | $-0.52 | $-1.28 | $-1.91 | $-1.22 | $-3.12 | $-1.54 | $-1.74 | $-1.75 | $-0.00 | $-0.00 | $-0.00 |
| Net margin | -12.5% | -39.0% | -32.7% | -60.1% | -383.3% | -22.2% | -22.1% | -19.5% | -21.2% | -21.2% | -10.9% |
| ROIC | — | -38.7% | -47.0% | -37.0% | -57.9% | -22.2% | -9.9% | -12.3% | -20.4% | -16.1% | -1.2% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Aemetis stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 65% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Aemetis pay a dividend?
Not currently.
Is Aemetis a good stock to buy?
We do not give buy or sell advice. Aemetis scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.